Literature DB >> 9949157

Endogenous interleukin-8 (IL-8) surge in granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization.

T Watanabe1, Y Kawano, S Kanamaru, T Onishi, S Kaneko, Y Wakata, R Nakagawa, A Makimoto, Y Kuroda, Y Takaue, J E Talmadge.   

Abstract

The relationship between stem cell mobilization with granulocyte colony-stimulating factor (G-CSF) and the endogenous production of interleukin-8 (IL-8), macrophage inflammatory protein-1alpha (MIP-1alpha), tumor necrosis factor-alpha (TNF-alpha), and interferon-gamma (IFN-gamma) was studied in normal donors for allogeneic peripheral blood stem cell (PBSC) transplantation. G-CSF was administered to 20 normal donors at a dose of 10 microg/kg/d for 5 days with aphereses on days 5 and 6 of G-CSF treatment. Cytokine serum levels were measured using an enzyme-linked immunosorbent assay (ELISA) before and during G-CSF treatment. Before treatment, the average level of IL-8 was 7.1 pg/mL, increasing to 207.0 pg/mL on day 5 and 189.1 pg/mL on day 6. Serum IL-8 levels correlated CD34(+) cell numbers (P =.0151 and P =.0005 on days 5 and 6, respectively) and colony-forming unit-granulocyte-macrophage (CFU-GM) numbers (P =.0019 and P =.0010 on days 5 and 6, respectively). Furthermore, preapheresis serum IL-8 levels correlated with the yield of CD34(+) cells (P =.0027). In contrast, before treatment, the average levels of MIP-1alpha, TNF-alpha, and IFN-gamma were 70.1, 4.03, and 3.84 pg/mL, respectively, and no significant changes in the levels of these cytokines were observed during G-CSF treatment. These studies suggest that IL-8 production may be critical to G-CSF-induced stem cell mobilization, although the underlying mechanism could not be clarified.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949157

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Interleukin 8/KC enhances G-CSF induced hematopoietic stem/progenitor cell mobilization in Fancg deficient mice.

Authors:  Yan Li; Wen Xing; Yong-Zheng He; Shi Chen; Steven D Rhodes; Jin Yuan; Yuan Zhou; Jun Shi; Jie Bai; Feng-Kui Zhang; Wei-Ping Yuan; Tao Cheng; Ming-Jiang Xu; Feng-Chun Yang
Journal:  Stem Cell Investig       Date:  2014-10-31

2.  Ageing and endothelial progenitor cell release of proangiogenic cytokines.

Authors:  Erich Kushner; Gary Van Guilder; Owen MacEneaney; Jared Greiner; Jennifer Cech; Brian Stauffer; Christopher Desouza
Journal:  Age Ageing       Date:  2009-12-29       Impact factor: 10.668

3.  Longitudinal relationships between rheumatoid factor and cytokine expression by immunostimulated peripheral blood lymphocytes from patients with rheumatoid arthritis: New insights into B-cell activation.

Authors:  John M Davis; Cynthia S Crowson; Keith L Knutson; Sara J Achenbach; Michael A Strausbauch; Terry M Therneau; Eric L Matteson; Sherine E Gabriel; Peter J Wettstein
Journal:  Clin Immunol       Date:  2020-01-08       Impact factor: 3.969

4.  G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils.

Authors:  Hoainam T Nguyen-Jackson; Haiyan S Li; Huiyuan Zhang; Erika Ohashi; Stephanie S Watowich
Journal:  J Leukoc Biol       Date:  2012-09-27       Impact factor: 4.962

5.  Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice.

Authors:  Johannes F M Pruijt; Perry Verzaal; Ronald van Os; Evert-Jan F M de Kruijf; Marianke L J van Schie; Alberto Mantovani; Annunciata Vecchi; Ivan J D Lindley; Roel Willemze; Sofie Starckx; Ghislain Opdenakker; Willem E Fibbe
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

6.  STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction.

Authors:  Hoainam Nguyen-Jackson; Athanasia D Panopoulos; Huiyuan Zhang; Haiyan S Li; Stephanie S Watowich
Journal:  Blood       Date:  2010-02-25       Impact factor: 22.113

7.  Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9).

Authors:  J F Pruijt; W E Fibbe; L Laterveer; R A Pieters; I J Lindley; L Paemen; S Masure; R Willemze; G Opdenakker
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

Review 8.  Effects and safety of granulocyte colony-stimulating factor in healthy volunteers.

Authors:  Paolo Anderlini
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

9.  Overcoming the response plateau in multiple myeloma: a novel bortezomib-based strategy for secondary induction and high-yield CD34+ stem cell mobilization.

Authors:  Ruben Niesvizky; Tomer M Mark; Maureen Ward; David S Jayabalan; Roger N Pearse; Megan Manco; Jessica Stern; Paul J Christos; Lena Mathews; Tsiporah B Shore; Faiza Zafar; Karen Pekle; Zhaoying Xiang; Scott Ely; Donna Skerret; Selina Chen-Kiang; Morton Coleman; Maureen E Lane
Journal:  Clin Cancer Res       Date:  2013-01-28       Impact factor: 12.531

10.  Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization.

Authors:  Tsutomu Watanabe; Hiroko Suzuya; Toshihiro Onishi; Sachiyo Kanai; Michiya Kaneko; Hiroyoshi Watanabe; Ryuji Nakagawa; Yoshifumi Kawano; Yoichi Takaue; Yasuhiro Kuroda; James E Talmadge
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.